Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Aren van Waarde

Showing results (51-60 of 102) with videos related to

Pageof 11
Sort By:
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|December 3, 2016
Synthesis and Evaluation of the Estrogen Receptor β-Selective Radioligand 2-<sup>18</sup>F-Fluoro-6-(6-Hydroxynaphthalen-2-yl)Pyridin-3-ol: Comparison with 16α-<sup>18</sup>F-Fluoro-17β-EstradiolInês F Antunes, Aren van Waarde, Rudi A J O Dierckx, et al.
European Journal of Nuclear Medicine and Molecular Imaging|February 28, 2009
Steroid hormones affect binding of the sigma ligand 11C-SA4503 in tumour cells and tumour-bearing ratsAnna A Rybczynska, Philip H Elsinga, Jurgen W Sijbesma, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|November 10, 2004
Tumor imaging with 2 sigma-receptor ligands, 18F-FE-SA5845 and 11C-SA4503: a feasibility studyAren van Waarde, Anne Rixt Buursma, Geke A P Hospers, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 25, 2012
11C-hydroxytryptophan uptake and metabolism in endocrine and exocrine pancreasValentina Di Gialleonardo, Alberto Signore, Ena A Scheerstra, et al.
Nuclear Medicine and Biology|August 6, 2003
Evaluation of [18F]FHPG as PET tracer for HSVtk gene expressionErik F J de Vries, Ingrid J van Dillen, Aren van Waarde, et al.
Synapse (New York, N.Y.)|May 15, 2014
Acute social defeat does not alter cerebral 5-HT2A receptor binding in male Wistar ratsAnniek K D Visser, Peter Meerlo, Anders Ettrup, et al.
Medicinal Research Reviews|January 28, 2017
Potential Therapeutic Applications of Adenosine A<sub>2A</sub> Receptor Ligands and Opportunities for A<sub>2A</sub> Receptor ImagingAren van Waarde, Rudi A J O Dierckx, Xiaoyun Zhou, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 11, 2012
18F-FEAnGA for PET of β-glucuronidase activity in neuroinflammationInês F Antunes, Janine Doorduin, Hidde J Haisma, et al.
Psychopharmacology|July 11, 2015
Pridopidine selectively occupies sigma-1 rather than dopamine D2 receptors at behaviorally active dosesKristoffer Sahlholm, Jurgen W A Sijbesma, Bram Maas, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|August 14, 2013
In vivo responses of human A375M melanoma to a σ ligand: 18F-FDG PET imagingAnna A Rybczynska, Marco de Bruyn, Nisha K Ramakrishnan, et al.
Pageof 11

Showing results (51-60 of 102) with videos related to

Sort By:
Pageof 11
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|December 3, 2016
Synthesis and Evaluation of the Estrogen Receptor β-Selective Radioligand 2-<sup>18</sup>F-Fluoro-6-(6-Hydroxynaphthalen-2-yl)Pyridin-3-ol: Comparison with 16α-<sup>18</sup>F-Fluoro-17β-EstradiolInês F Antunes, Aren van Waarde, Rudi A J O Dierckx, et al.
European Journal of Nuclear Medicine and Molecular Imaging|February 28, 2009
Steroid hormones affect binding of the sigma ligand 11C-SA4503 in tumour cells and tumour-bearing ratsAnna A Rybczynska, Philip H Elsinga, Jurgen W Sijbesma, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|November 10, 2004
Tumor imaging with 2 sigma-receptor ligands, 18F-FE-SA5845 and 11C-SA4503: a feasibility studyAren van Waarde, Anne Rixt Buursma, Geke A P Hospers, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 25, 2012
11C-hydroxytryptophan uptake and metabolism in endocrine and exocrine pancreasValentina Di Gialleonardo, Alberto Signore, Ena A Scheerstra, et al.
Nuclear Medicine and Biology|August 6, 2003
Evaluation of [18F]FHPG as PET tracer for HSVtk gene expressionErik F J de Vries, Ingrid J van Dillen, Aren van Waarde, et al.
Synapse (New York, N.Y.)|May 15, 2014
Acute social defeat does not alter cerebral 5-HT2A receptor binding in male Wistar ratsAnniek K D Visser, Peter Meerlo, Anders Ettrup, et al.
Medicinal Research Reviews|January 28, 2017
Potential Therapeutic Applications of Adenosine A<sub>2A</sub> Receptor Ligands and Opportunities for A<sub>2A</sub> Receptor ImagingAren van Waarde, Rudi A J O Dierckx, Xiaoyun Zhou, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 11, 2012
18F-FEAnGA for PET of β-glucuronidase activity in neuroinflammationInês F Antunes, Janine Doorduin, Hidde J Haisma, et al.
Psychopharmacology|July 11, 2015
Pridopidine selectively occupies sigma-1 rather than dopamine D2 receptors at behaviorally active dosesKristoffer Sahlholm, Jurgen W A Sijbesma, Bram Maas, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|August 14, 2013
In vivo responses of human A375M melanoma to a σ ligand: 18F-FDG PET imagingAnna A Rybczynska, Marco de Bruyn, Nisha K Ramakrishnan, et al.
Pageof 11